Cargando…

A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53

Detalles Bibliográficos
Autor principal: Glazer, Robert I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248136/
https://www.ncbi.nlm.nih.gov/pubmed/21317445
_version_ 1782220200522809344
author Glazer, Robert I.
author_facet Glazer, Robert I.
author_sort Glazer, Robert I.
collection PubMed
description
format Online
Article
Text
id pubmed-3248136
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-32481362012-01-18 A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53 Glazer, Robert I. Oncotarget Commentaries Impact Journals LLC 2010-10-17 /pmc/articles/PMC3248136/ /pubmed/21317445 Text en Copyright: © 2010 Glazer http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
spellingShingle Commentaries
Glazer, Robert I.
A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
title A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
title_full A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
title_fullStr A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
title_full_unstemmed A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
title_short A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
title_sort new therapeutic basis for treating li-fraumeni syndrome breast tumors expressing mutated tp53
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248136/
https://www.ncbi.nlm.nih.gov/pubmed/21317445
work_keys_str_mv AT glazerroberti anewtherapeuticbasisfortreatinglifraumenisyndromebreasttumorsexpressingmutatedtp53
AT glazerroberti newtherapeuticbasisfortreatinglifraumenisyndromebreasttumorsexpressingmutatedtp53